The Pharmaceutical and Life Sciences industry operates within a constantly changing global ecosystem. It is currently undergoing a transformation, driven by key trends.
- Value-Based Care: the move to value-based care is driven by the demand for proven therapy outcomes, creating opportunities for innovative treatments with clear benefits.
- Prevention and Cure: breakthroughs in genomics, precision medicine and AI are enabling the prevention of disease and the development of cures. This improves outcomes and lowers costs.
- Empowered Patients: due to easier access to information and digital tools, patients are nowadays more informed and engaged in their healthcare. This empowers them to play a more active role in their health and wellness, which is driving the demand for personalized and patient-centric solutions.
- Technology Integration: As technology giants are entering the healthcare sector, they disrupt the market as we know it. This can lead to better patient experiences and healthcare delivery.
KPMG’s global network of Pharma and Life Sciences professionals understands how these trends affect the industry. With our experience and expertise, we guide industry leaders and empower business practices.
Through our consulting services, we have earned the trust of leading healthcare organizations and pharma companies in Switzerland, helping them succeed in this competitive landscape.
Martin Rohrbach
Partner, Head Internal Audit, Risk and Compliance Services (IARCS), Sector Head Life Sciences
KPMG Switzerland
Market & Industry Challenges
Technological Frontiers
We help players in the life sciences sector to navigate the digital revolution with all its opportunities and challenges. As companies transition to digital operations, they face the task of integrating advanced technologies, such as artificial intelligence (AI) or machine learning.
This shift also requires significant investment in cybersecurity to protect sensitive health data and adherence to digital health regulations. KPMG supports life sciences businesses embracing digital transformation by integrating new technologies into their operations and developing tailored digital strategies.
Growth Opportunities
In the rapidly evolving life sciences sector, companies need to perform thorough due diligence to evaluate the value, risks and opportunities associated with mergers and acquisitions (M&A). We specialize in providing end-to-end support for M&A activities, including due diligence, valuation, and post-merger integration.
For early-phase life sciences companies, achieving commercial success requires a robust growth strategy. KPMG supports organizations in preparing for launch events and guiding them on the path to commercial growth. We also offer transaction support for licensing and development partnering opportunities. Additionally, we help you ensure that your M&A activities align with laws and regulations so that you can avoid legal and financial repercussions.
Supply Chain Integrity and operations transformation
Supply chain integrity and resilience are critical in the life sciences sector, where product availability can directly impact patient health. However, companies face challenges in creating robust supply chains that can withstand disruptions from global events or regulatory changes.
A resilient supply chain requires strategic planning and investment in technology for real-time tracking as well as diversification of suppliers and manufacturing locations. Life sciences firms must prioritize supply chain resilience to ensure the continuous delivery of essential medical products. Ensuring agile and efficient operations is the foundation of future success.
Protect your business
As regulations constantly evolve, companies must stay informed and agile so as to adapt to new requirements. This includes complying with international laws and regulations regarding product development, clinical trials, marketing approvals and post-market surveillance.
Non-compliance can lead to costly penalties, product recalls, and reputational damage. Life sciences companies must invest in compliance programs and training to mitigate risks and ensure patient safety across the whole healthcare system. Risk management and compliance are key to diversifying suppliers and manufacturing locations. Life sciences firms must prioritize supply chain resilience to ensure the continuous delivery of essential medical products. Agile and efficient operations are the foundation of future success.
Our services
We provide the experience, resources and knowledge necessary for your transformation. We offer a range of audit, advisory and tax services to help our clients grow their business, enhance performance, and manage risks. Our client focus, commitment to excellence, and consistent delivery have allowed us to build trusted relationships with clients across the healthcare and life sciences sector. At KPMG, our life sciences experts are dedicated to leveraging their in-depth sector expertise and insights.
Our specialized teams understand how data analytics, intelligent automation, and artificial intelligence can be used to inform life sciences research, processes, and decision-making.
Learn more with our thought leadership and research
Your contacts
Haven’t found what you were looking for?
In the fast-paced world of biotech companies, adapting strategies is essential. This is especially true for Swiss biotech companies undergoing mergers and acquisitions (M&A).
